Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapy.

Shi P, Wu Q, Zhang Y, Chen T, Warrick JI, DeGraff DJ, Raman JD, Chen G

Open source

DOI
10.1002/2056-4538.70077
Published
2026 Mar
Container
The journal of pathology. Clinical research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/2056-4538.70077,
  title = {Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapy.},
  author = {Shi P and Wu Q and Zhang Y and Chen T and Warrick JI and DeGraff DJ and Raman JD and Chen G},
  year = {2026},
  journal = {The journal of pathology. Clinical research},
  doi = {10.1002/2056-4538.70077},
  url = {https://doi.org/10.1002/2056-4538.70077}
}

RIS

TY  - JOUR
TI  - Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapy.
AU  - Shi P
AU  - Wu Q
AU  - Zhang Y
AU  - Chen T
AU  - Warrick JI
AU  - DeGraff DJ
AU  - Raman JD
AU  - Chen G
PY  - 2026
JO  - The journal of pathology. Clinical research
DO  - 10.1002/2056-4538.70077
UR  - https://doi.org/10.1002/2056-4538.70077
ER  - 

APA

P, S., Q, W., Y, Z., T, C., JI, W., DJ, D., JD, R., & G, C. (2026). Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapy.. The journal of pathology. Clinical research. https://doi.org/10.1002/2056-4538.70077

Source records